Application no. and date | 16862727.1 (espacenet) (Federated) (European Patent Register), 20161026 | Patent/reg. no. and date | DK/EP 3370723, 20201216 | Publication date | 20180912 | Priority no. and date | US 201562251026 P, 20151104, US 201662297740 P, 20160219, US 201662321623 P, 20160412 | EP pub. no. and date |
EP 3370723 20180912 | Effective date | | Applicant/owner | Eiger Biopharmaceuticals, Inc., 2155 Park Boulevard
Palo Alto, CA 94306, US | Applicant ref. no. | V2101-003-DK | Inventor | CORY, David A., c/o Eiger Biopharmaceuticals, Inc. 2155 Park Boulevard
Palo Alto, California 94306, US, CHOONG, Ingrid, c/o Eiger Biopharmaceuticals, Inc. 2155 Park Boulevard
Palo Alto, California 94306, US, GLENN, Jeffrey S., c/o Eiger Biopharmaceuticals, Inc. 2155 Park Boulevard
Palo Alto, California 94306, US | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/427 (2006.01) , A61K 31/4545 (2006.01) , A61K 38/21 (2006.01) , A61K 45/00 (2006.01) , A61K 9/14 (2006.01) , A61K 9/20 (2006.01) , A61K 9/48 (2006.01) , A61P 31/12 (2006.01) | Title | BEHANDLING AF HEPATITIS DELTA-VIRUSINFEKTION | Int. application no. | US2016058937 | Int. publication no. | WO2017079009 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|